FIELD: pharmaceutics.
SUBSTANCE: group of inventions relates to the pharmaceutical industry, namely to the use of lysobactin in a pharmaceutical composition for the treatment of cow mastitis. The use of the composition of lysobactin and at least one aminoglycoside antibiotic selected from a list consisting of kanamycin and neomycin is proposed for the treatment of mastitis in cows, where the ratio of lysobactin to aminoglycoside antibiotic is from 0.1 to 8. The pharmaceutical composition for the treatment of cow mastitis is prepared for intramammary administration into cow mammary glands.
EFFECT: above-described solution allows for the effective treatment of mastitis in cows.
10 cl, 12 dwg, 4 tbl, 15 ex
| Title | Year | Author | Number |
|---|---|---|---|
| LYSOBACTIN FOR USE IN TREATMENT OF BOVINE MASTITIS | 2016 |
|
RU2741764C2 |
| METHODS OF TREATING MICROBIAL INFECTIONS, INCLUDING MASTITIS | 2014 |
|
RU2662300C2 |
| PHARMACEUTICAL COMPOSITIONS AND METHOD OF TREATING MASTITES | 2013 |
|
RU2659430C2 |
| METHOD FOR PRODUCING SUSPENSION-EMULSION OF PRIMYCIN | 0 |
|
SU1837870A3 |
| MEDICATION FOR TREATING MASTITIS IN COWS IN LACTATION PERIOD | 2010 |
|
RU2432943C1 |
| COMPOSITIONS AND METHOD OF CONTROLLING INFECTIONS IN NON-HUMAN MAMMALS USING ACUTE PHASE PROTEINS | 2014 |
|
RU2725841C2 |
| PREPARATION FOR TREATING MASTITIS IN COWS IN LACTATION PERIOD | 2019 |
|
RU2698820C1 |
| STRAIN OF BACTERIA STREPTOCOCCUS DYSGALACTIAE FOR MAKING BIOPREPARATIONS FOR SPECIFIC PREVENTION OF MASTITIS IN COWS | 2023 |
|
RU2818361C1 |
| MAMMAL MILK CELLS, COMPOSITIONS CONTAINING THEM, AND USING THEM FOR TREATING MASTITIS | 2008 |
|
RU2446814C2 |
| METHOD OF PROPHYLAXIS OF MASTITIS IN HIGH-PRODUCING COWS | 2016 |
|
RU2668535C2 |
